ReviewFrontiers in pharmacology2026
Neglected tropical diseases: recent trends and challenges associated with its rapid diagnosis and effective therapeutic strategies.
Review in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neglected tropical diseases (NTDs) are a distinct group of illness that are primarily prevailing in the tropical regions. NTDs are caused by diverse pathogens including viruses, bacteria, parasites, fungi and toxins, resulting in adverse health, social and economic outcomes. Currently, more than one billion people globally are affected with NTDs, therefore, precise and rapid diagnostic mechanisms are integral for detection and control of NTDs. However, the NTDs programs are underinvested in the progression and enhancement of diagnostic tools. Due to this reason, WHO has released a new road map for NTD 2021-2030 and has pinpointed diagnostics as one of the precedence areas that require concrete action. In order to achieve the 2030 targets, WHO has also established Diagnostic Technical Advisory Group (DTAG) which will help in initiating collaboration among nations to drive advancement in this area. In this review, we explored the epidemiology and burden of NTDs, the challenges in their mitigation, and the available therapeutic interventions for managing these diseases. We have also highlighted the need to holistic approach like "One health" for an effective elimination of NTDs in affected areas. Elimination of NTDs will enhance the socioeconomic levels of the affected regions, thereby assisting in the accomplishment of few sustainable development goals. Thus, there is a need for worldwide commitment for funding to develop fast and safe therapeutic and diagnostic strategies for NTDs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.